WebFeb 12, 2024 · The main purpose of this study is to measure how well abemaciclib works in participants with early breast cancer who are taking hormone therapy after surgery. Participants must have breast cancer that is hormone receptor positive (HR+) and human epidermal receptor 2 positive (HER2+). WebResponse Rate and Safety of a Neoadjuvant Pertuzumab, Atezolizumab, Docetaxel, and Trastuzumab Regimen for Patients With ERBB2-Positive Stage II/III Breast Cancer: The …
Development and validation of the new HER2DX assay for …
WebDaphne is a 28-cycle progestin-only contraceptive, which should be taken at the same time of the day because it's low dosed and taking it earlier or later than your scheduled time … WebFeb 15, 2024 · The DAPHNE trial: A feasibility study of chemotherapy de-escalation based on response to neoadjuvant paclitaxel-HP (THP) in HER2-positive breast cancer … solitary summer
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast …
WebJul 17, 2013 · This randomized phase III trial studies lymph node dissection and radiation therapy to see how well it works compared to radiation therapy alone in treating patients with breast cancer previously treated with chemotherapy and surgery. Lymph node dissection may remove cancer cells that have spread to nearby lymph nodes in patients with breast ... WebApr 28, 2024 · Finally, the DAPHNE clinical trial, presented at the last San Antonio Breast Cancer Meeting in 2024, demonstrated that a de-escalation of the amount of … WebMay 20, 2013 · The Austrian Breast and Colorectal Cancer Study Group trial 4 had a mean age of 66 years, tumor size < 3 cm, and hormone treatment with either tamoxifen or anastrazole. The German Breast Cancer Group trial (GBCG-V) 5 allowed women as young as age 45 years and used a 2 × 2 factorial design (RT or no RT; Tam or no Tam). solitary thesaurus